Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Dai

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung CancerChen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 9, 2024
Risk factors for severe outcomes of coronavirus disease 2019 through the waves of the pandemic: Comparing patients with and without solid organ transplantationStephen B Lee, Ran Dai, Evan French, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 26, 2024
Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained-release tabletsWei-Jun Wang, Yue Li, Ya-Hui Hu, et al.
Frontiers in Medicine|January 22, 2024
Prevention of exacerbation in patients with moderate-to-very severe COPD with the intent to modulate respiratory microbiome: a pilot prospective, multi-center, randomized controlled trialJian-Lan Hua, Zi-Feng Yang, Qi-Jian Cheng, et al.
Pharmacological Research|August 27, 2022
Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphismsHao-Ran Dai, Yun Liu, Ke-Yu Lu, et al.
Nature Cell Biology|July 12, 2024
Full-length GSDME mediates pyroptosis independent from cleavageBo Zhou, Zhi-Hong Jiang, Meng-Ran Dai, et al.
Biomedical Chromatography : BMC|July 26, 2022
Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC-ESI-MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a surrogate matrixJia-Yi Long, Ya-Hui Hu, Ying Xia, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 9, 2024
A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic modelsHao-Ran Dai, Yun Liu, Hong-Li Guo, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 21, 2024
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infantsHao-Ran Dai, Hong-Li Guo, Ya-Hui Hu, et al.
Chinese Medical Journal|November 30, 2013
Association between the interleukin-13 gene and development of chronic obstructive pulmonary disease in southern Chinese Han population: a case-control studyYi Gong, Guo-chao Shi, Huan-ying Wan, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung CancerChen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 9, 2024
Risk factors for severe outcomes of coronavirus disease 2019 through the waves of the pandemic: Comparing patients with and without solid organ transplantationStephen B Lee, Ran Dai, Evan French, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 26, 2024
Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained-release tabletsWei-Jun Wang, Yue Li, Ya-Hui Hu, et al.
Frontiers in Medicine|January 22, 2024
Prevention of exacerbation in patients with moderate-to-very severe COPD with the intent to modulate respiratory microbiome: a pilot prospective, multi-center, randomized controlled trialJian-Lan Hua, Zi-Feng Yang, Qi-Jian Cheng, et al.
Pharmacological Research|August 27, 2022
Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphismsHao-Ran Dai, Yun Liu, Ke-Yu Lu, et al.
Nature Cell Biology|July 12, 2024
Full-length GSDME mediates pyroptosis independent from cleavageBo Zhou, Zhi-Hong Jiang, Meng-Ran Dai, et al.
Biomedical Chromatography : BMC|July 26, 2022
Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC-ESI-MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a surrogate matrixJia-Yi Long, Ya-Hui Hu, Ying Xia, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 9, 2024
A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic modelsHao-Ran Dai, Yun Liu, Hong-Li Guo, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 21, 2024
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infantsHao-Ran Dai, Hong-Li Guo, Ya-Hui Hu, et al.
Chinese Medical Journal|November 30, 2013
Association between the interleukin-13 gene and development of chronic obstructive pulmonary disease in southern Chinese Han population: a case-control studyYi Gong, Guo-chao Shi, Huan-ying Wan, et al.
Pageof 8